ASXChange of Director's Interest Notice - B Ridgeway
director_dealing announcement
ARTRYALIMITED ORDINARY (AYA) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Notification regarding unquoted securities - AYA
other announcement
KalkineIs Artrya (ASX:AYA) Redefining ASX Healthcare AI?
Highlights Artrya is bringing artificial intelligence into cardiac imaging to improve diagnostic accuracy. Healthcare AI is emerging as a distinct branch of the broader ASX technology theme. Clinical validation and regulatory progress remain central to medical AI adoption. Artrya highlights how healthcare AI is reshaping diagnostics through artificial intelligence, with a focus on cardiac imaging, clinical validation and real-world medical applications. Artificial intelligence continues...
Change of Director's Interest Notice - B Ridgeway
director_dealing announcement
Google NewsThis Insider Has Just Sold Shares In Artrya - simplywall.st
This Insider Has Just Sold Shares In Artrya simplywall.st
Artrya (ASX:AYA) Shares Edge Lower Today: Volatility, Volume, and Market Context Explained - Kalkine
Artrya (ASX:AYA) Shares Edge Lower Today: Volatility, Volume, and Market Context Explained Kalkine
Artrya appoints Clayton Hatch as Chief Financial Officer
other announcement
March Quarterly Activities Report and Appendix 4C
other announcement
Change of Director's Interest Notice - B Ridgeway
director_dealing announcement
AI Healthcare Buzz: Artrya Shares Surge on Imaging Momentum
Highlights Strong demand for AI-driven healthcare solutions lifts visibility Rising trading activity reflects growing market interest Clinical adoption and contracts remain key growth drivers Artrya gains attention as AI-driven healthcare imaging demand rises, highlighting growth opportunities within the All Ordinaries and evolving medical technology sector. Momentum in the Australian stock market is increasingly shifting toward healthcare technology, with Artrya Limited (ASX:AYA) draw...
Change in substantial holding from WAX/WAA/WAM/WMI
other announcement
Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
First Revenues from Salix Coronary Plaque Module
earnings announcement
Second US Commercial Customer - Northeast Georgia
other announcement
2025 Bell Potter Healthcare Conference Presentation
other announcement
2025 Canaccord Healthcare Conference Presentation
other announcement
Artrya AGM Chair Address and Company Presentation
other announcement
SAPPHIRE Study Expands With Inclusion of Ascension
other announcement
Issue of Shares on Exercise of Performance Rights
other announcement
Mass General Brigham to Participate in SAPPHIRE Study
other announcement
Becoming a substantial holder from WAM/WAA/WMI/WAX
other announcement
Completion of Placement and Cleansing Notice
capital_raise announcement